Cancer Pathways
Balance Sheet
Fiscal Year: 2024
Jan 1, 2024 – Dec 31, 2024
Assets in 2024 (Year End)
$3,606,632
Property, Plant, & Equipment (net)
41%
Cash & Equivalents
32%
Investments
27%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$1,336,400
Notes Payable / Debt (Non-Related)
96%
Payables & Accruals
4%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,632,377
$1,166,959
-29%
Receivables (Non-Related)
-
-
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$6,400
$0
-100%
Investments
$838,014
$972,599
+16%
Property, Plant, & Equipment (net)
$1,566,433
$1,467,074
-6%
Other Assets
-
-
-
Total Assets
$4,043,224
$3,606,632
-11%
Liabilities
2023
2024
Change
Payables & Accruals
$44,754
$51,134
+14%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$1,293,800
$1,285,266
-1%
Related-Party Payables
-
-
-
Other Liabilities
$0
-
-
Total Liabilities
$1,338,554
$1,336,400
0%
Net assets
2023
2024
Change
Restricted Net Assets
$30,000
$0
-100%
Unrestricted Net Assets
$2,674,670
$2,270,232
-15%
Net assets
2023
2024
Change
Net assets
+$2,704,670
+$2,270,232
-16%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)